Sutro Biopharma Stock Technical Analysis
| STRO Stock | USD 2.01 0.16 8.65% |
As of the 18th of January 2025, Sutro Biopharma has the Risk Adjusted Performance of (0.13), coefficient of variation of (611.49), and Variance of 26.21. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sutro Biopharma, as well as the relationship between them.
Sutro Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sutro, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SutroSutro |
Sutro Biopharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 11.5 | Strong Buy | 11 | Odds |
Most Sutro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sutro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sutro Biopharma, talking to its executives and customers, or listening to Sutro conference calls.
Sutro Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sutro Biopharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sutro Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Sutro Biopharma Trend Analysis
Use this graph to draw trend lines for Sutro Biopharma. You can use it to identify possible trend reversals for Sutro Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sutro Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Sutro Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Sutro Biopharma applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that Sutro Biopharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 58.06, which is the sum of squared deviations for the predicted Sutro Biopharma price change compared to its average price change.About Sutro Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sutro Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sutro Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sutro Biopharma price pattern first instead of the macroeconomic environment surrounding Sutro Biopharma. By analyzing Sutro Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sutro Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sutro Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Graham Number | 15.04 | 9.97 | 11.46 | 10.89 | Receivables Turnover | 9.52 | 4.26 | 4.9 | 4.66 |
Sutro Biopharma January 18, 2025 Technical Indicators
Most technical analysis of Sutro help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sutro from various momentum indicators to cycle indicators. When you analyze Sutro charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.85) | |||
| Mean Deviation | 3.6 | |||
| Coefficient Of Variation | (611.49) | |||
| Standard Deviation | 5.12 | |||
| Variance | 26.21 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.87) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | (0.86) | |||
| Maximum Drawdown | 25.6 | |||
| Value At Risk | (11.48) | |||
| Potential Upside | 6.4 | |||
| Skewness | (0.92) | |||
| Kurtosis | 1.71 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.68) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets | Return On Equity |
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.